Wolf JJ - Search Results

1

Ensuring the quality, potency and safety of vaccines during preclinical development.

Lebron JA, Wolf JJ, Kaplanski CV, Ledwith BJ. Lebron JA, et al. Among authors: wolf jj. Expert Rev Vaccines. 2005 Dec;4(6):855-66. doi: 10.1586/14760584.4.6.855. Expert Rev Vaccines. 2005. PMID: 16372881 Review.

2

Nonclinical safety assessment of vaccines and adjuvants.

Wolf JJ, Kaplanski CV, Lebron JA. Wolf JJ, et al. Methods Mol Biol. 2010;626:29-40. doi: 10.1007/978-1-60761-585-9_3. Methods Mol Biol. 2010. PMID: 20099119 Review.

3

Adaptation of the WHO guideline for residual DNA in parenteral vaccines produced on continuous cell lines to a limit for oral vaccines.

Lebron JA, Troilol PJ, Pacchione S, Griffiths TG, Harper LB, Mixson LA, Jackson BE, Michna L, Barnum AB, Denisova L, Johnson CN, Maurer KL, Morgan-Hoffman S, Niu Z, Roden DF, Wang Z, Wolf JJ, Hamilton TR, Laux KM, Soper KA, Ledwith BJ. Lebron JA, et al. Among authors: wolf jj. Dev Biol (Basel). 2006;123:35-44; discussion 55-73. Dev Biol (Basel). 2006. PMID: 16566435

4

Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats.

Wise LD, Wolf JJ, Kaplanski CV, Pauley CJ, Ledwith BJ. Wise LD, et al. Among authors: wolf jj. Birth Defects Res B Dev Reprod Toxicol. 2008 Dec;83(6):561-72. doi: 10.1002/bdrb.20174. Birth Defects Res B Dev Reprod Toxicol. 2008. PMID: 19025783

5

A multi-species assay for siRNA-mediated mRNA knockdown analysis without the need for RNA purification.

Wang Z, Pacchione SJ, Niu Z, Troilo PJ, Griffiths TG, Striano KL, Lebron JA, Wolf JJ. Wang Z, et al. Among authors: wolf jj. J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):174-9. doi: 10.1016/j.vascn.2010.09.006. Epub 2010 Sep 25. J Pharmacol Toxicol Methods. 2011. PMID: 20884365

6

Reliable quantification of mRNA in archived formalin-fixed tissue with or without paraffin embedding.

Wang Z, Lebron JA, Wolf JJ. Wang Z, et al. Among authors: wolf jj. J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:103-9. doi: 10.1016/j.vascn.2014.09.007. Epub 2014 Sep 30. J Pharmacol Toxicol Methods. 2015. PMID: 25280797

7

Characterization of integration frequency and insertion sites of adenovirus DNA into mouse liver genomic DNA following intravenous injection.

Wang Z, Troilo PJ, Griffiths TG 2nd, Harper LB, Barnum AB, Pacchione SJ, Pauley CJ, Lebron JA, Wolf J, Ledwith BJ. Wang Z, et al. Gene Ther. 2022 Jun;29(6):322-332. doi: 10.1038/s41434-021-00278-2. Epub 2021 Aug 18. Gene Ther. 2022. PMID: 34404916

8

Tumorigenicity assessments of Per.C6 cells and of an Ad5-vectored HIV-1 vaccine produced on this continuous cell line.

Ledwith BJ, Lanning CL, Gumprecht LA, Anderson CA, Coleman JB, Gatto NT, Balasubramanian G, Farris GM, Kemp RK, Harper LB, Barnum AB, Pacchione SJ, Mauer KL, Troilo PF, Brown ER, Wolf JJ, Lebronl JA, Lewis JA, Nichols WW. Ledwith BJ, et al. Among authors: wolf jj. Dev Biol (Basel). 2006;123:251-63; discussion 265-6. Dev Biol (Basel). 2006. PMID: 16566451

9

Application of PCR technology in vaccine product development.

Wolf JJ, Wang L, Wang F. Wolf JJ, et al. Expert Rev Vaccines. 2007 Aug;6(4):547-58. doi: 10.1586/14760584.6.4.547. Expert Rev Vaccines. 2007. PMID: 17669009 Review.

10

Development of Pandemic Vaccines: ERVEBO Case Study.

Wolf J, Jannat R, Dubey S, Troth S, Onorato MT, Coller BA, Hanson ME, Simon JK. Wolf J, et al. Vaccines (Basel). 2021 Feb 25;9(3):190. doi: 10.3390/vaccines9030190. Vaccines (Basel). 2021. PMID: 33668698 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page